Država: Združene države Amerike
Jezik: angleščina
Source: NLM (National Library of Medicine)
FLORFENICOL (UNII: 9J97307Y1H) (FLORFENICOL - UNII:9J97307Y1H)
Bayer HealthCare, LLC Animal Health Division
FLORFENICOL
FLORFENICOL 300 mg in 1 mL
INTRAMUSCULAR
PRESCRIPTION
LONCOR™ 300 is indicated for treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica , Pasteurella multocida , and Histophilus somni , and for the treatment of bovine interdigital phlegmon (foot rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus . Also, it is indicated for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica , Pasteurella multocida , and Histophilus somni . Do not use in animals that have shown hypersensitivity to florfenicol. This product contains materials that can be irritating to skin and eyes. Avoid direct contact with skin, eyes, and clothing. In case of accidental eye exposure, flush with water for 15 minutes. In case of accidental skin exposure, wash with soap and water. Remove contaminated clothing. Consult a physician if irritation persists. Accidental injection of this product may cause local irritatio
Loncor™ 300 is packaged in 250 mL and 500 mL glass sterile multiple-dose vials.
Abbreviated New Animal Drug Application
LONCOR 300- FLORFENICOL SOLUTION BAYER HEALTHCARE, LLC ANIMAL HEALTH DIVISION ---------- LONCOR 300 (FLORFENICOL) 300 MG/ML INJECTABLE SOLUTION FOR INTRAMUSCULAR AND SUBCUTANEOUS USE IN BEEF AND NON-LACTATING DAIRY CATTLE ONLY NOT FOR USE IN FEMALE DAIRY CATTLE 20 MONTHS OF AGE OR OLDER OR IN CALVES TO BE PROCESSED FOR VEAL CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION LONCOR™ 300 (florfenicol) 300 mg/mL Injectable Solution is a solution of the synthetic antibiotic florfenicol. Each milliliter of sterile LONCOR™ 300 contains 300 mg of florfenicol, 250 mg n-methyl-2-pyrrolidone, 150 mg propylene glycol, and polyethylene glycol qs. INDICATIONS LONCOR™ 300 is indicated for treatment of bovine respiratory disease (BRD) associated with _Mannheimia haemolytica_, _Pasteurella multocida_, and _Histophilus somni_, and for the treatment of bovine interdigital phlegmon (foot rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with _Fusobacterium necrophorum _and _Bacteroides_ _melaninogenicus_. Also, it is indicated for the control of respiratory disease in cattle at high risk of developing BRD associated with _Mannheimia haemolytica_, _Pasteurella_ _multocida_, and _Histophilus somni_. DOSAGE AND ADMINISTRATION FOR TREATMENT OF BOVINE RESPIRATORY DISEASE (BRD) AND BOVINE INTERDIGITAL PHLEGMON (FOOT ROT): LONCOR™ 300 should be administered by intramuscular injection to cattle at a dose rate of 20 mg/kg body weight (3 mL/100 lbs). A second dose should be administered 48 hours later. Alternatively, LONCOR™ 300 can be administered by a single subcutaneous (SC) injection to cattle at a dose rate of 40 mg/kg body weight (6 mL/100 lbs). Do not administer more than 10 mL at each site. The injection should be given only in the neck. NOTE: Intramuscular injection may result in local tissue reaction which persists beyond 28 days. This may result in trim loss of edible tissue at slaughter. Tissue reaction at injection sites other than the Preberite celoten dokument